P230 Adalimumab in Crohn’s disease is protective against periodontitis based on a validated oral health questionnaire
Hajeena Saravanapavan(University College Hospital), Andrew Smith(The Royal Free Hospital), M Ong(Eastman Dental Hospital), Maja Sabalić(Eastman Dental Hospital), S Inniss(University College Hospital), Francesco D’Aiuto(Eastman Dental Hospital), Shibanand Rath(University College Hospital), Fryad Majeed Rahman(University College Hospital)
Cited by 0
Related Papers
Periodontitis and cardiovascular diseases: Consensus report
|Journal Of Clinical Periodontology|2020|1.5k
Treatment of Periodontitis and Endothelial Function
|New England Journal of Medicine|2007|1.3k
Periodontitis and Systemic Inflammation: Control of the Local Infection is Associated with a Reduction in Serum Inflammatory Markers
|Journal of Dental Research|2004|740
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial
|The Lancet Diabetes & Endocrinology|2018|492
Short-term Effects of Intensive Periodontal Therapy on Serum Inflammatory Markers and Cholesterol
|Journal of Dental Research|2005|416